SLC7A5 and colonic neoplasm: It showed dramatic inhibition of l-[14C]-leucine uptake in both S2 LAT1 (IC50 = 0.14 μM) and human colon cancer (HT-29) LAT1 (IC50 = 0.06 μM) cells.